TSEN34
tRNA-splicing endonuclease subunit Sen34
Also known as: LENG5, SEN34, SEN34_HUMAN, SEN34L
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BSV6
- Gene
- TSEN34
- Ensembl
- ENSG00000170892
- Chromosome
- 19
- Canonical length
- 310 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes a catalytic subunit of the tRNA splicing endonuclease, which catalyzes the removal of introns from precursor tRNAs. The endonuclease complex is also associated with a pre-mRNA 3-prime end processing factor. A mutation in this gene results in the neurological disorder pontocerebellar hypoplasia type 2. Multiple alternatively spliced variants, encoding the same protein, have been identified.[provided by RefSeq, Oct 2009]
Canonical amino-acid sequenceUniProt
310 residues, UniProt reviewed canonical sequence.
>Q9BSV6|TSEN34
1 MLVVEVANGR SLVWGAEAVQ ALRERLGVGG RTVGALPRGP RQNSRLGLPL LLMPEEARLL
61 AEIGAVTLVS APRPDSRHHS LALTSFKRQQ EESFQEQSAL AAEARETRRQ ELLEKITEGQ
121 AAKKQKLEQA SGASSSQEAG SSQAAKEDET SDGQASGEQE EAGPSSSQAG PSNGVAPLPR
181 SALLVQLATA RPRPVKARPL DWRVQSKDWP HAGRPAHELR YSIYRDLWER GFFLSAAGKF
241 GGDFLVYPGD PLRFHAHYIA QCWAPEDTIP LQDLVAAGRL GTSVRKTLLL CSPQPDGKVV
301 YTSLQWASLQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TSEN34 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 53 nTPM
Expression across tissuesHPA
Tissue
- adrenal gland: 53 nTPM
- ovary: 37 nTPM
- testis: 35 nTPM
- blood vessel: 34 nTPM
- spleen: 34 nTPM
- liver: 33 nTPM
Single-cell type
- oligodendrocyte progenitor cells: 10 nCPM
- other brain neurons: 10 nCPM
- ependymal cells: 8.8 nCPM
- renal collecting duct principal cells: 8.7 nCPM
- bergmann glia: 7.8 nCPM
- astrocytes: 7.4 nCPM
Immune cell
- basophil: 5 nTPM
- neutrophil: 4.9 nTPM
- eosinophil: 1.9 nTPM
- classical monocyte: 0.6 nTPM
- intermediate monocyte: 0.5 nTPM
- MAIT T-cell: 0.4 nTPM
Brain region
- cerebellum: 6 nTPM
- cerebral cortex: 5.9 nTPM
- medulla oblongata: 5.9 nTPM
- amygdala: 5.6 nTPM
- white matter: 5.6 nTPM
- hippocampal formation: 5.4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TSEN34.
Disease | AllUniProt
Conditions TSEN34 is implicated in, by any mechanism.
- Pontocerebellar hypoplasia 2C (PCH2C) MIM:612390
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 213 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Pontocerebellar hypoplasia type 2C
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.59
- gnomAD pLI
- 0.36
- gnomAD missense Z
- -0.96
- DepMap mean gene effect
- -0.47
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- tRNA-splicing endonuclease
- tRNA intron endonuclease, catalytic domain-like
- tRNA endonuclease-like domain superfamily
- tRNA intron endonuclease, catalytic domain-like superfamily
- tRNA intron endonuclease, catalytic C-terminal domain
- TSEN34
- TSEN34, N-terminal domain
- TSEN34-like, N-terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TSEN34 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TSEN34 as an antibody target. Whether an autoantibody or antibody against TSEN34 could matter depends on whether native TSEN34 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TSEN34 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TSEN34 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...